Robert McDowell
2017
In 2017, Robert McDowell earned a total compensation of $1.3M as Chief Scientific Officer at MyoKardia.
Compensation breakdown
| Non-Equity Incentive Plan | $117,000 |
|---|---|
| Option Awards | $814,463 |
| Salary | $327,749 |
| Other | $1,000 |
| Total | $1,260,212 |
McDowell received $814.5K in option awards, accounting for 65% of the total pay in 2017.
McDowell also received $117K in non-equity incentive plan, $327.7K in salary and $1K in other compensation.
Rankings
In 2017, Robert McDowell's compensation ranked 7,864th out of 14,666 executives tracked by ExecPay. In other words, McDowell earned more than 46.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,864 out of 14,666 | 46th |
Division Manufacturing | 2,950 out of 5,772 | 49th |
Major group Chemicals And Allied Products | 962 out of 2,075 | 54th |
Industry group Drugs | 748 out of 1,731 | 57th |
Industry Pharmaceutical Preparations | 586 out of 1,333 | 56th |
Source: SEC filing on April 16, 2018.
McDowell's colleagues
We found three more compensation records of executives who worked with Robert McDowell at MyoKardia in 2017.